To evaluate for diabetic ketoacidosis, which tests are appropriate?

To evaluate for diabetic ketoacidosis, which tests are appropriate?

• A. Venous blood gas, Beta-hydroxybutyrate, Basic metabolic panel
• B. Arterial blood gas, Serum ketones, Comprehensive metabolic panel
• C. Random glucose, Serum osmolality, CBC
• D. Lactate, Troponin, C-reactive protein

Answer: (A)

Diagnosing diabetic ketoacidosis focuses on confirming the combination of metabolic acidosis, ketosis, and hyperglycemia, and then assessing electrolyte and kidney status to guide treatment. A venous blood gas gives the acid-base picture—pH and bicarbonate—and helps quantify the metabolic acidosis that accompanies DKA. Measuring beta-hydroxybutyrate directly detects the predominant ketone driving DKA, providing a sensitive and specific indicator of ketosis rather than relying on less precise ketone tests. A basic metabolic panel then quickly reveals critical electrolytes and kidney function, especially potassium and bicarbonate reserve, which are essential for safe fluid and insulin therapy and for understanding the patient’s severity. Other options don’t align as well with the goal. An arterial blood gas can assess acid-base status but isn’t necessary when venous data suffices. Serum ketones alone may miss the key ketone (beta-hydroxybutyrate) responsible for DKA in many patients. A comprehensive metabolic panel adds liver-related tests and extra data that aren’t essential for initial DKA assessment, and tests like random glucose, lactate, troponin, or CRP don’t establish the diagnosis of DKA on their own.

Diagnosing diabetic ketoacidosis focuses on confirming the combination of metabolic acidosis, ketosis, and hyperglycemia, and then assessing electrolyte and kidney status to guide treatment. A venous blood gas gives the acid-base picture—pH and bicarbonate—and helps quantify the metabolic acidosis that accompanies DKA. Measuring beta-hydroxybutyrate directly detects the predominant ketone driving DKA, providing a sensitive and specific indicator of ketosis rather than relying on less precise ketone tests. A basic metabolic panel then quickly reveals critical electrolytes and kidney function, especially potassium and bicarbonate reserve, which are essential for safe fluid and insulin therapy and for understanding the patient’s severity.

Other options don’t align as well with the goal. An arterial blood gas can assess acid-base status but isn’t necessary when venous data suffices. Serum ketones alone may miss the key ketone (beta-hydroxybutyrate) responsible for DKA in many patients. A comprehensive metabolic panel adds liver-related tests and extra data that aren’t essential for initial DKA assessment, and tests like random glucose, lactate, troponin, or CRP don’t establish the diagnosis of DKA on their own.